ActiVein activein.co.il


Public lists: Medical Devices (6123)

ActiVein develops a patented, dual-action intravenous (IV) catheter that aims to replace the standard conventional "hospital IV line" by enabling both fluid infusion and blood withdrawal using a single vein over an entire hospitalization period, whereas the currently used device aims to allow, regularly, fluid infusion only.

ActiVein develops a patented, dual-action intravenous (IV) catheter that aims to replace the standard conventional "hospital IV line" by enabling both fluid infusion and blood withdrawal using a single vein over an entire hospitalization period, wher...Show all

Company (Alive / Active)

Phone:

Fax:

1 Leshmem St.
Israel

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
ActiVein $0M Nov 30, 2018
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related ActiVein Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Delcath Systems

New York, New York, United States
IPO / Went publicDelcath has developed a system to isolate the liver from the general circulatory system and to administer chemotherapy and other therapeutic agents directly to the liver. Using the Delcath system to deliver chemotherapy to the liver and cleanse the blood of the chemotherapy before its return from the liver into the patient's circulatory system protects other parts of the body from the harmful side-effects of chemotherapy. The Company believes that the use of the Delcath system in treatment of li...Show allLogin to see details

Bacchus Vascular

Santa Clara, California, United States
AcquiredBacchus Vascular, Inc. is a privately-held medical device company dedicated to the treatment of peripheral vascular disease. Dr. Thomas Fogarty, a noted inventor and cardiovascular surgeon, founded the company with the vision of transforming blood clot removal from peripheral blood vessels into a fast, simple, minimally-invasive catheter-based procedure. Thousands of patients suffering from DVT and other occlusive vascular diseases have been treated worldwide to date using the company's Trellis ...Show allLogin to see details
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Vascular coupling device Mar 26, 2003 Jul 06, 2010 Patent